• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Androgen receptor-positive, triple-negative breast cancer.

作者信息

Gucalp Ayca, Traina Tiffany A

机构信息

Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

出版信息

Cancer. 2017 May 15;123(10):1686-1688. doi: 10.1002/cncr.30683. Epub 2017 Apr 12.

DOI:10.1002/cncr.30683
PMID:28406524
Abstract
摘要

相似文献

1
Androgen receptor-positive, triple-negative breast cancer.雄激素受体阳性的三阴性乳腺癌。
Cancer. 2017 May 15;123(10):1686-1688. doi: 10.1002/cncr.30683. Epub 2017 Apr 12.
2
Targeting the androgen receptor in triple-negative breast cancer.靶向三阴性乳腺癌中的雄激素受体。
Curr Probl Cancer. 2016 Mar-Aug;40(2-4):141-150. doi: 10.1016/j.currproblcancer.2016.09.004. Epub 2016 Sep 20.
3
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype.三阴性乳腺癌中的雄激素受体：无靶点亚型的潜在靶点。
Cancer Treat Rev. 2018 Jul;68:102-110. doi: 10.1016/j.ctrv.2018.06.005. Epub 2018 Jun 11.
4
[Androgen receptors in breast cancer: Expression, value and therapeutic prospects].[乳腺癌中的雄激素受体：表达、价值及治疗前景]
Bull Cancer. 2017 Apr;104(4):363-369. doi: 10.1016/j.bulcan.2017.01.005. Epub 2017 Feb 16.
5
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?雄激素受体靶向治疗是否为三阴性乳腺癌的新兴治疗策略？
Cancer Treat Rev. 2015 Jun;41(6):547-53. doi: 10.1016/j.ctrv.2015.04.009. Epub 2015 Apr 29.
6
[Androgen receptor-positive triple negative breast cancer: From biology to therapy].[雄激素受体阳性三阴性乳腺癌：从生物学到治疗]
Bull Cancer. 2020 Apr;107(4):506-516. doi: 10.1016/j.bulcan.2019.12.012. Epub 2020 Mar 4.
7
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.维生素D与雄激素受体靶向疗法治疗三阴性乳腺癌
Breast Cancer Res Treat. 2016 May;157(1):77-90. doi: 10.1007/s10549-016-3807-y. Epub 2016 Apr 27.
8
Triple Negative Breast Cancer: A Tale of Two Decades.三阴性乳腺癌：二十年的故事
Anticancer Agents Med Chem. 2017;17(4):491-499. doi: 10.2174/1871520616666160725112335.
9
Triple-negative breast cancer: molecular subtypes and targeted therapy.三阴性乳腺癌：分子亚型与靶向治疗。
Curr Opin Obstet Gynecol. 2014 Feb;26(1):34-40. doi: 10.1097/GCO.0000000000000038.
10
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.针对三阴性乳腺癌的分子亚型：了解多样性以推动该领域的发展。
Oncologist. 2017 Sep;22(9):1086-1093. doi: 10.1634/theoncologist.2017-0095. Epub 2017 May 30.

引用本文的文献

1
Beyond Triple-Negative: High Prevalence of Quadruple-Negative Breast Cancer in African Americans.超越三阴性：非裔美国人中四阴性乳腺癌的高患病率
Biomedicines. 2024 Jul 9;12(7):1522. doi: 10.3390/biomedicines12071522.
2
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype.鉴定一种可靶向的 JAK-STAT 富集的雄激素受体和雄激素受体剪接变异阳性的三阴性乳腺癌亚型。
Cell Rep. 2023 Dec 26;42(12):113461. doi: 10.1016/j.celrep.2023.113461. Epub 2023 Nov 17.
3
Rare subtypes of triple negative breast cancer: Current understanding and future directions.
三阴性乳腺癌的罕见亚型：当前认识与未来方向。
NPJ Breast Cancer. 2023 Jun 23;9(1):55. doi: 10.1038/s41523-023-00554-x.
4
Tumor-infiltrating lymphocytes status, programmed death-ligand 1 expression, and clinicopathological features of 41 cases of pure apocrine carcinoma of the breast: a retrospective study based on clinical pathological analysis and different immune statuses.41例乳腺单纯大汗腺癌的肿瘤浸润淋巴细胞状态、程序性死亡配体1表达及临床病理特征：一项基于临床病理分析和不同免疫状态的回顾性研究
Gland Surg. 2022 Jun;11(6):1037-1046. doi: 10.21037/gs-22-248.
5
Apocrine lesions of the breast.乳房大汗腺病变。
Virchows Arch. 2022 Jan;480(1):177-189. doi: 10.1007/s00428-021-03185-4. Epub 2021 Sep 18.
6
Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.三阴性大汗腺癌：一种罕见的病理亚型，比其他三阴性乳腺癌预后更好。
J Surg Oncol. 2020 Nov;122(6):1232-1239. doi: 10.1002/jso.26129. Epub 2020 Jul 15.
7
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.利用不同的依赖性：如何识别和靶向雄激素受体阳性与四阴性乳腺癌。
Horm Cancer. 2018 Apr;9(2):82-94. doi: 10.1007/s12672-017-0314-5. Epub 2018 Jan 16.
8
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.胰岛素样生长因子-2 和雄激素受体作为三阴性乳腺癌的治疗靶点。
Int J Mol Sci. 2017 Nov 2;18(11):2305. doi: 10.3390/ijms18112305.
9
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer.肿瘤微环境对肿瘤浸润淋巴细胞的影响：聚焦于乳腺癌
Breast Cancer (Auckl). 2017 Sep 25;11:1178223417731565. doi: 10.1177/1178223417731565. eCollection 2017.
10
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.雄激素受体表达与基于人群的前瞻性队列研究中的乳腺癌死亡率。
Breast Cancer Res Treat. 2017 Oct;165(3):645-657. doi: 10.1007/s10549-017-4343-0. Epub 2017 Jun 22.